Catalytic asymmetric synthesis of enantioenriched β-nitronitrile bearing a C-CF3 stereogenic center

Ajay Jakharab, Prathibha Kumariab, Mohd Nazishab, Noor-ul H. Khan*ab, Rukhsana I. Kureshyab, Sayed H. R. Abdiab and E. Sureshbc
aInorganic Materials and Catalysis Division, CSIR-Central Salt and Marine Chemicals Research Institute, G. B. Marg, Bhavnagar-364 002, Gujarat, India. E-mail: khan251293@yahoo.in
bAcademy of Scientific and Innovative Research, CSIR-Central Salt and Marine Chemicals Research Institute, G. B. Marg, Bhavnagar-364 002, Gujarat, India
cAnalytical Division and Centralized Instrument Facility, CSIR-Central Salt and Marine Chemicals Research Institute, G. B. Marg, Bhavnagar-364 002, Gujarat, India

Received 3rd January 2016 , Accepted 15th March 2016

First published on 17th March 2016


Abstract

CF3 substituted β-nitronitriles with an all-carbon quaternary stereogenic center have been synthesized via asymmetric cyanation reaction. In situ generated chiral TiIV salen complexes were used as catalysts for asymmetric addition of TMSCN to nitroolefins containing a trifluoromethylated prochiral center in the β-position, to afford the corresponding β-nitronitriles in excellent yield (up to 93%) with good enantioselectivity (up to 99%). This newly developed catalytic protocol led to the efficient synthesis of useful but challenging chiral α,α′-disubstituted β-amino acids.


Introduction

The catalytic enantioselective construction of an all-carbon stereocenter containing a CF3 group is important from the perspective of producing novel bio-active motifs for their commercial exploitation. However, assembling these structural motifs in an enantioselective manner is particularly challenging and a current area of research under intense investigation. Despite the challenges, the necessity of producing such CF3 group containing compound is driven by the fact that incorporation of trifluoromethyl group to organic molecules improve their lipophilicity, bioavailability, and metabolic stability thereby bioactivity.1 Consequently, these facts clearly manifest its importance in pharmaceuticals, agrochemicals, and material science.2 Though, great progress has been made to incorporate CF3 group to organic scaffolds but surprisingly the synthesis of CF3 substituted quaternary carbon stereocenter have received scant attention.3 Shibata and coworkers for the first time reported an asymmetric synthesis of an all-carbon stereocenter bearing a CF3 group through cyanation of β-aryl-β-CF3-disubstituted enones.4 Although different strategies were followed to construct CF3-containing5a–l and fluorinated5m quaternary compounds however, to the best of our knowledge a direct route for the synthesis of tetrasubstituted carbon quaternary stereocenters via cyanation of CF3-bearing simple disubstituted olefins, is not reported nevertheless there are only few reports available in literature for the synthesis of chiral β-nitro nitrile by using simple nitroalkenes.6 The asymmetric addition of cyanide to activated olefins like α,β-unsaturated ketones,7 α,β-unsaturated imides,8 α,β-unsaturated N-acylpyrroles,9 α,β-unsaturated esters,10 and nitroalkenes are scarcely studied when compared to the asymmetric cyanation of C[double bond, length as m-dash]O11 and C[double bond, length as m-dash]N12 double bonds. More specifically, in our continuous interest in the development of enantioselective cyanation reactions, herein we are disclosing the cyanation reaction which is synthetically different from the other existing reports. In this report, we wish to describe an efficient catalytic protocol for the enantioselective conjugate Michael addition of TMSCN to β-CF3-β-disubstituted nitroalkenes to give CF3-substituted β-nitro nitrile (Scheme 1).
image file: c6ra00093b-s1.tif
Scheme 1 Construction of CF3 substituted quaternary stereocentres via asymmetric cyanation reaction.

Recently, we reported asymmetric addition of cyanide to nitro olefins,6f however in the present report, in order to incorporate CF3 group, we prepared desired nitroolefins 1a–l (ref. 5a) for their asymmetric cyanation. Thus obtained CF3 substituted nitro nitrile products can be readily transformed into important compound like α-CF3 substituted β-amino acid, CF3 substituted amino alcohol and trifluromethylated diammine.

Results and discussion

In our quest to develop a simple catalytic system for asymmetric cyanation of β,β-disubstituted nitro alkenes our first choice was the use of chiral Ti(OiPr)4:salen complexes as catalysts as these have proven record in the cyanation of carbonyls and activated olefins.11,6d Accordingly, various chiral ligands (L1–L11, 10 mol%) (Fig. 1) with Ti(OiPr)4 (10 mol%) were used to in situ generate active catalyst for the cyanation of 1a used as a model substrate and TMSCN as a cyanide source in toluene at room temperature (Table 1). We observed that the yield and enantioselectivity of product 2a were greatly affected by the substituents on the salen ligands: as shown in Table 1 (entries 1–11), the best salen ligand was L3, bearing tBu groups at the 3′- and the 5′-positions in the salicylidene phenyl rings (90% yield, 77% ee, entry 3). In addition, dimer (L6 & L7; entries 6 & 7), polymer (L8; entry 8) and macrocyclic (L9–L11; entries 9–11) salen ligands were not so effective both in terms of reactivity and enantioselectivity. Therefore, taking L3 as best among the screened ligand, and in order to further improve the results, we varied titanium metal sources viz., Ti(OEt)4, Ti(OBu)4, Ti(OtBu)4 and TiCl4 (entry 12–15). We observed that the chiral L3 ligand in combination with Ti(OtBu) generates most effective catalyst to give the desired product in 95% yield and 80% ee (entry 14).
image file: c6ra00093b-f1.tif
Fig. 1 Ligands used in the model reaction.
Table 1 Ligand screening in the model reactiona

image file: c6ra00093b-u1.tif

Entry Ligand (10 mol%) Metal source (10 mol%) Time (h) Yieldb (%) eec (%)
a Enantioselective hydrocyanation reaction of 1a (0.1 mmol) was carried out with Ti:salen catalyst in toluene (1 mL) using TMSCN (0.20 mmol) as a source of cyanide.b Isolated yield.c ee were determined by chiral HPLC using OD-H column.
1 L1 Ti(OiPr)4 08 91 54
2 L2 Ti(OiPr)4 08 92 40
3 L3 Ti(OiPr)4 08 90 77
4 L4 Ti(OiPr)4 24 Trace
5 L5 Ti(OiPr)4 12 82 67
6 L6 Ti(OiPr)4 10 88 59
7 L7 Ti(OiPr)4 10 88 74
8 L8 Ti(OiPr)4 12 85 42
9 L9 Ti(OiPr)4 12 82 40
10 L10 Ti(OiPr)4 12 80 15
11 L11 Ti(OiPr)4 12 80 25
12 L3 Ti(OEt)4 08 90 74
13 L3 Ti(OBu)4 08 92 77
14 L3 Ti(OtBu)4 08 95 80
15 L3 TiCl4 14 80 75


Having established, the combination of L3:Ti(OtBu)4 as effective catalyst, we experimented on optimization of solvent, temperature and catalyst loading. First we screened solvents viz., toluene, benzene, CH2Cl2, CHCl3, DCE, THF, and dioxane to carry out the asymmetric cyanation reaction under the above optimized condition (Table 2, entries 1–7), however toluene remained the solvent of choice (entry 1). Temperature had significant effect on enantioselectivity of product (entries 1, 8–10). Lowering the temperature from room temperature to 0 °C showed beneficial effect on the product ee (from rt 80% to 89%) though the reaction took longer time (24 h, entry 9) to reach completion. A further lowering of the temperature (−10 °C) did not have any positive impact on the product ee at the same time reaction became very sluggish (48 h, entry 10). Therefore, 0 °C (entry 9) was taken as optimum for further studies on catalyst loading varied through 2, 5, 7, 10 and 15 mol% (entries 11–13, 9 and 14 respectively). However, 10 mol% catalyst loading (entry 9) was found to be optimum.

Table 2 Optimization of the reaction conditionsa

image file: c6ra00093b-u2.tif

Entry Catalyst loading (mol%) Solvent Temp. (°C) Time (h) Yieldb (%) eec (%)
a Enantioselective hydrocyanation reaction of 1a (0.1 mmol) was carried out with L3:Ti(OtBu)4 catalyst using TMSCN (0.20 mmol) as a source of cyanide.b Isolated yield.c ee were determined by chiral HPLC using OD-H column.
1 10 Toluene RT 08 95 80
2 10 Benzene RT 08 91 78
3 10 CH2Cl2 RT 08 92 52
4 10 CHCl3 RT 10 86 54
5 10 THF RT 16 73 58
6 10 1,4-Dioxane RT 20 70 59
7 10 DCE RT 20 76 48
8 10 Toluene 10 16 93 85
9 10 Toluene 0 24 92 89
10 10 Toluene −10 48 76 89
11 2 Toluene 0 48 Trace
12 5 Toluene 0 48 54 89
13 7 Toluene 0 36 70 89
14 15 Toluene 0 16 93 86


To further improve the results we considered using different like N-oxides, phenols, molecular sieve (4 Å) but the results (Table S1) were rather not very encouraging (see ESI).

Having established the reaction parameters for the use of the L3:Ti(OtBu)4 catalyst in the asymmetric cyanation reaction with the substrate 1a and TMSCN at 0 °C, we next extended this protocol to a range of trifluoromethylated nitroalkenes (1a–l) to check the general applicability of our system and the results are summarized in Table 3. Both electron donating and withdrawing substituents at different positions on the aryl ring of the trifluoromethylated nitroalkenes (entries 2–11) afforded the products in high yields and enantioselectivities. The results of these studies do not indicate any pronounced effect of electronic properties of the substrates used herein.

Table 3 Substrate scope in the synthesis of β-nitro nitrile using L3:Ti(OtBu)4 catalysta

image file: c6ra00093b-u3.tif

Entry R Time (h) Yieldb (%) eec (%)
a Enantioselective hydrocyanation reaction of 1a–l (0.1 mmol) was carried out with L3:Ti(OtBu)4 catalyst (10 mol%) in toluene (1 mL) using TMSCN (0.20 mmol) as a source of cyanide.b Isolated yield.c ee were determined by chiral HPLC using OD-H column.d ee were determined after crystallization by chiral HPLC using OD-H column.e The absolute configuration was determined by single-crystal X-ray structure.f The reaction of 1d was carried out at room temperature for 60 h.g Reaction of 1a carried out in 10 mmol scale.
1 C6H5 (1a) 24 91 89 (99)d (S)e
2 3-MeC6H4 (1b) 24 87 83
3 4-MeC6H4 (1c) 24 92 88
4f 2-MeOC6H4 (1d) 60 52 75
5 4-MeOC6H4 (1e) 24 93 88
6 4-ClC6H4 (1f) 24 86 82
7 4-FC6H4 (1g) 24 88 83
8 3-FC6H4 (1h) 24 87 79
9 2-FC6H4 (1i) 24 80 99
10 3,4-FC6H3 (1j) 24 88 74
11 3-CF3C6H4 (1k) 24 85 80
12 C6H5CH2 (1l) 36 82 53
13g C6H5 (1a) 24 91 89


Moreover, benzyl substituted nitroalkene (1l) gave product with 53% ee though in good yield (82%; entry 12). Since these products are new we have characterized them with fully, however for determining absolute configuration single-crystal X-ray structure of product 2a was determined, which was found to be S with (+) rotation. For rest of the compounds the rotation was found to be (+) but in the absence of single crystals of these compounds absolute conference was not determined. However, based on the absolute configuration of 2a, a working model for asymmetric induction is proposed (Fig. 2) where the nitro group of alkene weakly coordinates to Ti(IV) and due to the presence of tBu-groups in the catalyst only Re-face is open to attack of cyanide at the β-position of the nitroalkene.


image file: c6ra00093b-f2.tif
Fig. 2 Proposed model for asymmetric induction.

As a showcase we have subjected the nitrile product 2a to reduction, hydrolysis and Boc-protection6a,6d to produce enantioenriched N-Boc protected trifluoromethylated β-amino acid 5a where no racemization of the intermediates was noticed under the reaction conditions used for this conversion (Scheme 2). Analogous β-amino acids are very important molecules in pharmaceuticals.13


image file: c6ra00093b-s2.tif
Scheme 2 Synthetic transformations of product 2a.

Experimental section

Different aldehydes and reagents were used as received. All the solvents used in the present study were dried by known purification technique.14 NMR spectra were obtained with a Bruker F113V spectrometer (500 MHz/200 MHz) and are referenced internally with TMS. Splitting patterns were reported as s, singlet; d, doublet; dd, doublet of doublet; t, triplet; m, multiplet. Enantiomeric excess (ee) were determined by HPLC using Daicel Chiralcel OD-H chiral columns with 2-propanol/hexane as eluent. Optical rotations were determined by automatic polarimeter. For the product purification flash chromatography was performed using silica gel 100–200 mesh. Different ligands L1–L4,15a–d L6–L8,15e–g and L9–L11 (ref. 15h) were synthesized according to the previously reported methods. Trifluoromethylated nitroalkenes (1a–l) were prepared according to the reported literature.5a

Synthesis of ligand L5

(i) Synthesis of 4-(adamantan-1-yl)-2-(tert-butyl)phenol (A1). To a solution of 2-tert-butylphenol (10 mmol) and 1-admantanol (10 mmol) were dissolved in DCM (20 mL). Con. H2SO4 (0.6 mL) was added dropwise slowly to reaction mixture at 0 °C over 10 minutes. The reaction mixture was stirred two hours at room temperature and neutralized by adding 5% aqueous sodium hydroxide solution. The resulting mixture was extracted with DCM (40 mL × 3) and organic phase washed with brine and dried over anhydrous sodium sulphate. After removing solvent, crude product was purified by silica gel chromatography using EtOAc/hexane to afford the desired product (yield 42%).
(ii) Synthesis of 5-(adamantan-1-yl)-3-(tert-butyl)-2-hydroxybenzaldehyde (A2). A mixture of 2,6-lutidine (2.0 mmol), SnCl4 (1.0 mmol) and 4-(adamantan-1-yl)-2-(tert-butyl)phenol (3.5 mmol) in 15 mL of dry toluene was stirred at room temperature under inert atmosphere. After 1 h paraformaldehyde (1.3 mmol) was added to reaction mixture and heated under reflux for 8 h and the reaction progress was checked on TLC. Once the reaction was completed, the reaction mixture was allowed to cool to 25 °C and mixture of water and diethyl ether (40 mL) each was added to it. The resulting emulsion was filtered through a pad of Celite and the layers were separated. The organic phase was washed with water, brine, and dried over anhydrous Na2SO4, and then concentrated on rota-evaporater. The crude product was purified by silica gel chromatography using EtOAc/hexane as eluent to afford the desired product (yield 88%).
(iii) (R,R)-(−)N,N-Bis(5-adamantyl-3-tert-butylsalicylidene)-1,2-cyclohexanediamine (L5). 5-(Adamantan-1-yl)-3-(tert-butyl)-2-hydroxybenzaldehyde (1 mmol) was dissolved in 3 mL of ethanol/DCM (9[thin space (1/6-em)]:[thin space (1/6-em)]1). The solution of (1R,2R)-(−)-cyclohexanediamine (0.5 mmol) in ethanol (0.5 mL) was added slowly to reaction mixture, and stirred at room temperature for 6–8 h. After completion of reaction, the resulting solution was concentrated on rota-evaporater and yellow solid washed with cold ethanol to give desired compound (yield 87%).

Typical procedure for asymmetric cyanation of trifluoromethylated nitro olefins

Ti(OtBu)4 (10 mol%, 0.01 mmol) was added to stirring solution of ligand L3 (10 mol%, 0.01 mmol) in freshly dry toluene (1 mL) under inert atmosphere at room temperature. After stirring for 45 min, substrate (0.1 mmol) was added and resulting solution was cooled to 0 °C. To cooled solution TMSCN (0.2 mmol) was added slowly drop wise over 20 min. The reaction was monitored by TLC, after the completion of the reaction, aqueous NaHCO3 was added to quench the reaction and extracted with DCM (15 mL × 3). The organic layer was washed with brine, dried over anhydrous Na2SO4 and solvent was removed on rotavapor. The residue was purified by silica gel column chromatography using EtOAc/hexane (10[thin space (1/6-em)]:[thin space (1/6-em)]90) to afford the desired product. The purified new products are characterized by 1H NMR, 13C NMR and 19F NMR and LCMS, HRMS.

Conclusions

We have developed an enantioselective hydrocyanation reaction of β-trifluoromethyl-β-disubstituted nitroalkenes using TMSCN catalyzed by a Ti(IV) salen complex. In the present protocol we have disclosed the first and efficient enantioselective transformation to synthesis β-nitronitrile containing all-carbon quaternary stereogenic centers bearing a trifluoromethyl group with very good enantioselectivity (up to 99%). The product β-nitronitrile was conveniently transformed to the corresponding trifluoromethylated β-amino acids.

Acknowledgements

CSIR–CSMCRI communication no. 111/2015. Authors are thankful to CSIR for SRF, CSIR Network Project on Catalysis and DST, New Delhi for Project (SR/S1/IC-24/2013) on Catalysis for financial assistance. Ajay Jakhar is also thankful to AcSIR for Ph.D. registration and “Analytical Discipline and Centralized Instrumental Facilities” for providing instrumentation facilities.

Notes and references

  1. (a) H. Hasegawa, M. Muraoka, K. Matsui and A. Kojima, Bioorg. Med. Chem. Lett., 2003, 13, 3471 CrossRef CAS PubMed; (b) P. R. Daga and R. J. Doerksen, J. Comput. Chem., 2008, 29, 1945 CrossRef CAS PubMed; (c) W. K. Hagmann, J. Med. Chem., 2008, 51, 4359 CrossRef CAS PubMed; (d) R. Filler and R. Saha, Future Med. Chem., 2009, 1, 777 CrossRef CAS PubMed; (e) H. Xie, Y. Zhang, S. Zhang, X. Chen and W. Wang, Angew. Chem., Int. Ed., 2011, 50, 11773 CrossRef CAS PubMed.
  2. (a) J. T. Welch and S. Eswarakrishman, Fluorine in Bioorganic Chemistry, Wiley, New York, 1991 Search PubMed; (b) B. E. Smart, J. Fluorine Chem., 2001, 109, 3 CrossRef CAS; (c) T. Mita, T. Kikuchi, T. Mizukoshi, M. Yaosaka and M. Komoda, WO2005085216, 2005; (d) K. Mìller, C. Faeh and F. Diederich, Science, 2007, 317, 1881 CrossRef PubMed; (e) D. O'Hagan, Chem. Soc. Rev., 2008, 37, 308 RSC; (f) G. Chaume, N. Lensen, C. Caupéne and T. Brigaud, Eur. J. Org. Chem., 2009, 5717 CrossRef CAS; (g) S. Lectard, Y. Hamashima and M. Sodeoka, Adv. Synth. Catal., 2010, 352, 2708 CrossRef CAS; (h) Y. Ozoe, M. Asahi, F. Ozoe, K. Nakahira and T. Mita, Biochem. Biophys. Res. Commun., 2010, 391, 744 CrossRef CAS PubMed; (i) J. Nie, H.-C. Guo, D. Cahard and J.-A. Ma, Chem. Rev., 2011, 111, 455 CrossRef CAS PubMed.
  3. For selected reviews on trifluoromethylation of organic compounds, see: (a) S. Purser, P. R. Moore, S. Swallow and V. Gouverneur, Chem. Soc. Rev., 2008, 37, 320 RSC; (b) O. A. Tomashenko and V. V. Grushin, Chem. Rev., 2011, 111, 4475 CrossRef CAS PubMed; (c) Y. Ye and M. S. Sanford, Synlett, 2012, 23, 2005 CrossRef CAS PubMed; (d) T. Furuya, A. S. Kamlet and T. Ritter, Nature, 2011, 473, 470 CrossRef CAS PubMed; (e) X.-F. Wu, H. Neumann and M. Beller, Chem.–Asian J., 2012, 7, 1744 CrossRef CAS PubMed; (f) A. Studer, Angew. Chem., Int. Ed., 2012, 51, 8950 CrossRef CAS PubMed; (g) Y.-Y. Huang, X. Yang, Z. Chen, F. Verpoort and N. Shibata, Chem.–Eur. J., 2015, 21, 8664 CrossRef CAS PubMed.
  4. H. Kawai, S. Okusu, E. Tokunaga, H. Sato, M. Shiro and N. Shibata, Angew. Chem., Int. Ed., 2012, 51, 4959 CrossRef CAS PubMed.
  5. (a) J.-R. Gao, H. Wu, B. Xiang, W.-B. Yu, L. Han and Y.-X. Jia, J. Am. Chem. Soc., 2013, 135, 2983 CrossRef CAS PubMed; (b) Q. Chen, G. Wang, X. Jiang, Z. Xu, L. Lin and R. Wang, Org. Lett., 2014, 16, 1394 CrossRef CAS PubMed; (c) P. Kwiatkowski, A. Cholewiak and A. Kasztelan, Org. Lett., 2014, 16, 5930 CrossRef CAS PubMed; (d) C.-H. Ma, T.-R. Kang, L. He and Q.-Z. Liu, Eur. J. Org. Chem., 2014, 3981 CrossRef CAS; (e) H. Wu, R.-R. Liu and Y.-X. Jia, Synlett, 2014, 25, 457 CAS; (f) W. Chen, Z. Jing, K. F. Chin, B. Qiao, Y. Zhao, L. Yan, C.-H. Tan and Z. Jiang, Adv. Synth. Catal., 2014, 392, 1256 Search PubMed; (g) F.-L. Liu, J.-R. Chen, B. Feng, X.-Q. Hu, L.-H. Ye, L.-Q. Lu and W.-J. Xiao, Org. Biomol. Chem., 2014, 12, 105 Search PubMed; (h) J. Chen, S. Meng, L. Wang, H. Tang and Y. Huang, Chem. Sci., 2015, 6, 4184 RSC; (i) L. Wang, J. Chen and Y. Huang, Angew. Chem., Int. Ed., 2015, 54, 15414 CrossRef CAS PubMed; (j) D. Du, Y. Jiang, Q. Xu, X.-Y. Tang and M. Shi, ChemCatChem, 2015, 7, 1366 CrossRef CAS; (k) Y. Zhu, X. Li, Q. Chen, J. Su, F. Jia, S. Qiu, M. Ma, Q. Sun, W. Yan, K. Wang and R. Wang, Org. Lett., 2015, 17, 3826 CrossRef CAS PubMed; (l) H. Wu, R.-R. Liu, C. Shen, M.-D. Zhang, J. Gao and Y.-X. Jia, Org. Chem. Front., 2015, 2, 124 RSC; (m) D. Yan, Q. Li and C. Wang, Chin. J. Chem., 2012, 30, 2714 CAS.
  6. (a) J. C. Anderson, A. J. Blake, M. Mills and P. D. Ratcliffe, Org. Lett., 2008, 10, 4141 CrossRef CAS PubMed; (b) L. Bernardi, F. Fini, M. Fochi and A. Ricci, Synlett, 2008, 12, 1857 Search PubMed; (c) P. Bernal, R. Fernández and J. M. Lassaletta, Chem.–Eur. J., 2010, 16, 7714 CrossRef CAS PubMed; (d) L. Lin, W. Yin, X. Fu, J. Zhang, X. Ma and R. Wang, Org. Biomol. Chem., 2012, 10, 83 RSC; (e) M. North and J. M. Watson, ChemCatChem, 2013, 5, 2405 CrossRef CAS PubMed; (f) A. Jakhar, A. Sadhukhan, N. H. Khan, S. Saravanan, R. I. Kureshy, S. H. R. Abdi and H. C. Bajaj, ChemCatChem, 2014, 6, 2656 CrossRef CAS.
  7. (a) H. Iida, T. Moromizato, H. Hamana and K. Matsumoto, Tetrahedron Lett., 2007, 48, 2037 CrossRef CAS; (b) Y. Tanaka, M. Kanai and M. Shibasaki, J. Am. Chem. Soc., 2008, 130, 6072 CrossRef CAS PubMed; (c) J. Yang, Y. Wang, W. Shaoxiang and F.-X. Chen, Synlett, 2009, 3365 CAS; (d) Y. Tanaka, M. Kanai and M. Shibasaki, J. Am. Chem. Soc., 2010, 132, 8862 CrossRef CAS PubMed; (e) N. Kurono, N. Nii, Y. Sakaguchi, M. Uemura and T. Ohkuma, Angew. Chem., Int. Ed, 2011, 50, 5541 CrossRef CAS PubMed; (f) B. A. Provencher, K. J. Bartelson, Y. Liu, B. M. Foxman and L. Deng, Angew. Chem., Int. Ed., 2011, 50, 10565 CrossRef CAS PubMed; (g) H. Kawai, S. Okusu, E. Tokunaga, H. Sato, M. Shiro and N. Shibata, Angew. Chem., Int. Ed., 2012, 51, 4959 CrossRef CAS PubMed; (h) S. Lin, Y. Wei and F. Liang, Chem. Commun., 2012, 48, 9879 RSC; (i) S. Ramesh and A. Lalitha, Acta Chim. Slov., 2013, 60, 689 CAS; (j) C. Dong, T. Song, X.-F. Bai, Y.-M. Cui, Z. Xu and L.-W. Xu, Catal. Sci. Technol., 2015, 5, 4755 RSC; (k) X.-P. Zeng, Z.-Y. Cao, X. Wang, L. Chen, F. Zhou, F. Zhu, C.-H. Wang and J. Zhou, J. Am. Chem. Soc., 2016, 138, 416 CrossRef CAS PubMed.
  8. (a) G. M. Sammis and E. N. Jacobsen, J. Am. Chem. Soc., 2003, 125, 4442 (J. Am. Chem. Soc., 2004, 126, 9928) CrossRef CAS PubMed; (b) C. Mazet and E. N. Jacobsen, Angew. Chem., Int. Ed., 2008, 47, 1762 CrossRef CAS PubMed; (c) N. Madhavana and M. Weck, Adv. Synth. Catal., 2008, 350, 419 CrossRef.
  9. (a) T. Mita, K. Sasaki, M. Kanai and M. Shibasaki, J. Am. Chem. Soc., 2005, 127, 514 CrossRef CAS PubMed; (b) I. Fujimori, T. Mita, K. Maki, M. Shiro, A. Sato, S. Furusho, M. Kanaia and M. Shibasaki, Tetrahedron, 2007, 63, 5820 CrossRef CAS.
  10. (a) J. Wang, W. Li, Y. Liu, Y. Chu, L. Lin, X. Liu and X. Feng, Org. Lett., 2010, 12, 1280 CrossRef CAS PubMed; (b) H. Mukherjee and C. A. Martinez, ACS Catal., 2011, 1, 1010 CrossRef CAS; (c) Y. Liu, S. Shirakawa and K. Maruoka, Org. Lett., 2013, 15, 1230 CrossRef CAS PubMed.
  11. (a) N. H. Khan, R. I. Kureshy, S. H. R. Abdi, S. Agrawal and R. V. Jasra, Coord. Chem. Rev., 2008, 252, 593 CrossRef CAS; (b) N. H. Khan, R. I. Kureshy, S. H. R. Abdi, H. C. Bajaj and A. Sadhukhan, “Asymmetric Cyanation Reactions” Elsevier Publication in Comprehensive Inorganic Chemistry II, Elsevier, Oxford, 2013, vol. 6, p. 413 Search PubMed; (c) M. North, D. L. Usanov and C. Young, Chem. Rev., 2008, 108, 5146 CrossRef CAS PubMed; (d) W. Wang, X. Liu, L. Lin and X. Feng, Eur. J. Org. Chem., 2010, 4751 CrossRef CAS; (e) Z. Zhang, Z. Wang, R. Zhang and K. Ding, Angew. Chem., Int. Ed., 2010, 49, 6746 CrossRef CAS PubMed; (f) H. Pellissier, Adv. Synth. Catal., 2015, 357, 857 CrossRef CAS; (g) N. Kurono and T. Ohkuma, ACS Catal., 2016, 6, 989 CrossRef CAS.
  12. (a) S. J. Zuend, M. P. Coughlin, M. P. Lalonde and E. N. Jacobsen, Nature, 2009, 461, 968 CrossRef CAS PubMed; (b) J. Wang, X. Liu and X. Feng, Chem. Rev., 2011, 111, 6947 CrossRef CAS PubMed; (c) X. H. Cai and B. Xie, ARKIVOC, 2014, 1, 205 Search PubMed; (d) S. Saravanan, N. H. Khan, A. Jakhar, A. Ansari, R. I. Kureshy, S. H. R. Abdi and G. Kumar, RSC Adv., 2015, 5, 99951 RSC.
  13. (a) J. X. Qiu, E. J. Petersson, E. E. Matthews and A. Schepartz, J. Am. Chem. Soc., 2006, 128, 11338 CrossRef CAS PubMed; (b) B. Weiner, W. Szymaski, D. B. Janssen, A. J. Minnaarda and B. L. Feringa, Chem. Soc. Rev., 2010, 39, 1656 RSC; (c) A. Ishii, M. Yasumoto, T. Yamazaki, K. Mogi and T. Masuda, US Pat., 20110152536 A1, 23 Jun 2011.
  14. D. D. Perrin, W. L. F. Armarego and D. R. Perrin, Purification of Laboratory Chemicals, Pergamon, New York, 1981 Search PubMed.
  15. (a) C. M. Mascarenhas, S. P. Miller, P. S. White and J. P. Morken, Angew. Chem., Int. Ed., 2001, 40, 601 CrossRef CAS; (b) X. Yao, M. Qiu, W. Lu, H. Chen and Z. Zheng, Tetrahedron: Asymmetry, 2001, 12, 197 CrossRef CAS; (c) J. F. Larrow and E. N. Jacobsen, J. Org. Chem., 1994, 59, 1939 CrossRef CAS; (d) S.-K. Chen, D. Peng, H. Zhou, L.-W. Wang, F.-X. Chen and X.-M. Feng, Eur. J. Org. Chem., 2007, 639 CrossRef; (e) R. I. Kureshy, N. H. Khan, S. H. R. Abdi, S. T. Patel and R. V. Jasra, Tetrahedron Lett., 2001, 42, 2915 CrossRef CAS; (f) R. I. Kureshy, N. H. Khan, S. H. R. Abdi, S. Singh, I. Ahmad, R. V. Jasra and A. P. Vyas, J. Catal., 2004, 224, 229 CrossRef CAS; (g) R. I. Kureshy, M. Kumar, S. Agrawal, N. H. Khan, B. Dangi, S. H. R. Abdi and H. C. Bajaj, Chirality, 2011, 23, 76 CrossRef CAS PubMed; (h) S. Saravanan, N. H. Khan, P. K. Bera, R. I. Kureshy, S. H. R. Abdi, P. Kumari and H. C. Bajaj, ChemCatChem, 2013, 5, 1374 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available. CCDC 1412289. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6ra00093b

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.